| Literature DB >> 33959916 |
Hirotaka Watanabe1, Rei Murakami2, Hideyuki Okano3.
Abstract
Amyloid β (Aβ) peptides are the main component of the characteristic insoluble deposits in brain parenchyma and small blood vessels in the patients afflicted with Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA). These small peptides are attributed to the pathogenesis of both AD and CAA, suggesting an important index for disease stage and progression. In the brain tissue, Aβs are released mainly from neuronal cells into extracellular space. Here, we describe a step-by-step protocol to measure Aβs secreted from human pluripotent stem cell-derived neuronal cells.Entities:
Keywords: Amyloid β (Aβ); Enzyme-Linked Immuno Sorbent Assay (ELISA); Neuronal differentiation; induced pluripotent stem cell (iPSC); β-Secretase; γ-Secretase
Mesh:
Substances:
Year: 2022 PMID: 33959916 DOI: 10.1007/7651_2021_407
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745